Maciej Kokoszka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maciej Kokoszka has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Michalina Chodór
Medical University of Silesia in Katowice, Katowice, Poland
13 shared publications - Aleksandra Maria Tomaszewska
University Clinical Hospital of Bialystok, Białystok, Poland
9 shared publications - Aleksandra Mierniczek
Independent Public Healthcare Institution of the Ministry of Interior and Administration in Gdańsk, Gdańsk, Poland
5 shared publications - Aleksandra Ćwirko-Godycka
Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland
5 shared publications - Kinga Karczewska
7th Naval Hospital, Gdansk, Poland
5 shared publications - Krzysztof Feret
Faculty of Medicine, Academy of Silesia, 40-555 Katowice, Poland
5 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
BURNOUT AND MORAL INJURY AMONG RESIDENTS AND EARLY-CAREER PHYSICIANS: AN INTERNATIONAL REVIEW OF OBSERVATIONAL EVIDENCE
Background. Burnout among healthcare workers is now recognised as a public-health concern in its own right, with residents and early-career physicians disproportionately affected. The construct of moral injury — distress arising when clinicians cannot act in accordance with their professional values because of system-level constraints — has been proposed as a complement to the classical burnout framework. Aim. To synthesise contemporary observational evidence on the epidemiology of burnout, its principal risk factors, and the role of moral injury among residents and early-career physicians, with particular attention to the Polish context. Methods. A literature review of observational studies published between 2009 and 2025 was conducted in PubMed, Scopus, and Web of Science, following the STROBE statement for reporting. Because of methodological heterogeneity, no quantitative meta-analysis was attempted; findings were integrated through qualitative narrative synthesis. Results. Burnout prevalence in this population ranged from approximately 30% to over 60%, depending on geography, specialty, and measurement instrument [11,12]. Dominant risk factors were organisational: excessive workload, administrative load, restricted professional autonomy, and impaired work–life balance. Personal attributes rarely operated as independent predictors but appeared to modify risk. Moral injury emerged as a meaningful complement to burnout, capturing the value-conflict dimension that burnout scales tend to miss [8,9]. Conclusions. Burnout and moral injury together pose a serious challenge to healthcare systems. Prevention strategies that focus exclusively on individual resilience are unlikely to succeed; the evidence points instead to structural and organisational reform [31].
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessBURNOUT AND MORAL INJURY AMONG RESIDENTS AND EARLY-CAREER PHYSICIANS: AN INTERNATIONAL REVIEW OF OBSERVATIONAL EVIDENCE
Background. Burnout among healthcare workers is now recognised as a public-health concern in its own right, with residents and early-career physicians disproportionately affected. The construct of moral injury — distress arising when clinicians cannot act in accordance with their professional values because of system-level constraints — has been proposed as a complement to the classical burnout framework. Aim. To synthesise contemporary observational evidence on the epidemiology of burnout, its principal risk factors, and the role of moral injury among residents and early-career physicians, with particular attention to the Polish context. Methods. A literature review of observational studies published between 2009 and 2025 was conducted in PubMed, Scopus, and Web of Science, following the STROBE statement for reporting. Because of methodological heterogeneity, no quantitative meta-analysis was attempted; findings were integrated through qualitative narrative synthesis. Results. Burnout prevalence in this population ranged from approximately 30% to over 60%, depending on geography, specialty, and measurement instrument [11,12]. Dominant risk factors were organisational: excessive workload, administrative load, restricted professional autonomy, and impaired work–life balance. Personal attributes rarely operated as independent predictors but appeared to modify risk. Moral injury emerged as a meaningful complement to burnout, capturing the value-conflict dimension that burnout scales tend to miss [8,9]. Conclusions. Burnout and moral injury together pose a serious challenge to healthcare systems. Prevention strategies that focus exclusively on individual resilience are unlikely to succeed; the evidence points instead to structural and organisational reform [31].
- Open Access
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
THE ROLE OF THE MICROBIOME IN HASHIMOTO’S DISEASE - PATHOGENESIS AND THERAPEUTIC IMPLICATIONS: NARRATIVE REVIEW
Objective: The aim of this narrative review was to summarize the current state of knowledge regarding the role of the gut microbiome in the pathogenesis of Hashimoto’s disease and to discuss potential microbiome-targeted therapeutic strategies. Methods: A narrative literature review was conducted using publications indexed in the PubMed, Google Scholar and Scopus databases. Original research articles, systematic reviews, and meta-analyses focusing on Hashimoto’s disease and gut microbiota interactions were included. Most studies were selected from the past 10-15 years, with approximately 80% of the included literature published within the last five years (2021–2025), ensuring up-to-date evidence. Key findings: Available evidence indicates that patients with Hashimoto’s disease exhibit gut dysbiosis characterized by reduced microbial diversity, decreased abundance of short-chain fatty acid-producing bacteria, and an overrepresentation of potentially pathogenic microorganisms. These alterations are associated with impaired intestinal barrier integrity, increased systemic inflammation, and dysregulation of immune responses, particularly an imbalance between regulatory T cells and Th17 lymphocytes. Furthermore, microbiome disturbances may contribute to thyroid autoimmunity through mechanisms such as molecular mimicry and translocation of bacterial antigens. Emerging studies suggest that dietary modification, probiotic and synbiotic supplementation, and fecal microbiota transplantation may positively influence thyroid function and immune regulation. Conclusions: Although levothyroxine replacement remains the standard treatment for Hashimoto’s disease, modulation of the gut microbiome represents a promising adjunctive therapeutic approach. Further well-designed clinical trials are required to clarify causal relationships and evaluate the efficacy of microbiome-targeted interventions in autoimmune thyroid disease.
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
Open AccessTHE ROLE OF THE MICROBIOME IN HASHIMOTO’S DISEASE - PATHOGENESIS AND THERAPEUTIC IMPLICATIONS: NARRATIVE REVIEW
Objective: The aim of this narrative review was to summarize the current state of knowledge regarding the role of the gut microbiome in the pathogenesis of Hashimoto’s disease and to discuss potential microbiome-targeted therapeutic strategies. Methods: A narrative literature review was conducted using publications indexed in the PubMed, Google Scholar and Scopus databases. Original research articles, systematic reviews, and meta-analyses focusing on Hashimoto’s disease and gut microbiota interactions were included. Most studies were selected from the past 10-15 years, with approximately 80% of the included literature published within the last five years (2021–2025), ensuring up-to-date evidence. Key findings: Available evidence indicates that patients with Hashimoto’s disease exhibit gut dysbiosis characterized by reduced microbial diversity, decreased abundance of short-chain fatty acid-producing bacteria, and an overrepresentation of potentially pathogenic microorganisms. These alterations are associated with impaired intestinal barrier integrity, increased systemic inflammation, and dysregulation of immune responses, particularly an imbalance between regulatory T cells and Th17 lymphocytes. Furthermore, microbiome disturbances may contribute to thyroid autoimmunity through mechanisms such as molecular mimicry and translocation of bacterial antigens. Emerging studies suggest that dietary modification, probiotic and synbiotic supplementation, and fecal microbiota transplantation may positively influence thyroid function and immune regulation. Conclusions: Although levothyroxine replacement remains the standard treatment for Hashimoto’s disease, modulation of the gut microbiome represents a promising adjunctive therapeutic approach. Further well-designed clinical trials are required to clarify causal relationships and evaluate the efficacy of microbiome-targeted interventions in autoimmune thyroid disease.
- Open Access
- 16 April 2026
- Published by John Paul II University in Biała Podlaska in Health Problems of Civilization
Microplastics – why are they everywhere within the body and where do they come from? A review
Microplastics (MPs) have been detected in nearly all environmental compartments. The crucial routes of human exposure include the indoor environment, where the concentration of airborne fibers is higher than outdoors, the consumption of contaminated food, and contact with cookware, medical equipment, and personal care products made from or containing plastic. Depending on how MPs enter the body, through ingestion, inhalation, or dermal contact, they can reach a variety of organs. In this study, we focus on the detection of MPs and their consequences in several organs, which have not been sufficiently described in literature before, including the kidneys, placenta, testes, heart, brain, bone marrow, and in bodily secretions, namely semen and breast milk. To ensure the most accurate and up-to-date data, the presented results are based on papers published within the past three years. Experimental and clinical studies link exposure to MPs to oxidative stress, inflammation, dysbiosis, mitochondrial damage, fibrosis, and potential carcinogenic and neurotoxic effects. These mechanisms, occurring in the aforementioned tissues, raise concerns regarding fertility, fetal development, metabolic health, and neurodegeneration. However, further improvements in detection of MPs and contamination prevention methods are needed to minimize the potential health risks associated with exposure.
- 16 April 2026
- Published by John Paul II University in Biała Podlaska in Health Problems of Civilization
Open AccessMicroplastics – why are they everywhere within the body and where do they come from? A review
Microplastics (MPs) have been detected in nearly all environmental compartments. The crucial routes of human exposure include the indoor environment, where the concentration of airborne fibers is higher than outdoors, the consumption of contaminated food, and contact with cookware, medical equipment, and personal care products made from or containing plastic. Depending on how MPs enter the body, through ingestion, inhalation, or dermal contact, they can reach a variety of organs. In this study, we focus on the detection of MPs and their consequences in several organs, which have not been sufficiently described in literature before, including the kidneys, placenta, testes, heart, brain, bone marrow, and in bodily secretions, namely semen and breast milk. To ensure the most accurate and up-to-date data, the presented results are based on papers published within the past three years. Experimental and clinical studies link exposure to MPs to oxidative stress, inflammation, dysbiosis, mitochondrial damage, fibrosis, and potential carcinogenic and neurotoxic effects. These mechanisms, occurring in the aforementioned tissues, raise concerns regarding fertility, fetal development, metabolic health, and neurodegeneration. However, further improvements in detection of MPs and contamination prevention methods are needed to minimize the potential health risks associated with exposure.
- Open Access
- 25 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
ALGORITHMIC AUTHORITY VS. HUMAN TOUCH: A NARRATIVE REVIEW OF PATIENT TRUST AND CLINICAL AUTONOMY IN AI-ASSISTED DIAGNOSTICS
Introduction: Contemporary medicine is undergoing an unprecedented transformation driven by the integration of advanced artificial intelligence (AI) and large language models (LLMs) into clinical workflows. While these technologies objectively enhance diagnostic precision, their implementation creates a fundamental paradox: the increase in technological efficacy often correlates with a decline in patient trust, known as the "AI trust gap." This review examines the tension between algorithmic authority and the necessity of the "human touch," analyzing the impact of digital innovations on clinical autonomy and the patient-physician-AI triad. Materials and Methods: This study presents a detailed analysis of 44 peer-reviewed scientific articles published between 2022 and 2026. The review focuses on Clinical Decision Support Systems (CDSS) across key diagnostic areas, including radiology and pathology. The analysis encompasses the psychological mechanisms of AI acceptance, the risks of automation bias, and the potential of Explainable AI (XAI) to restore clinical transparency. Key Findings: Research reveals that the mere disclosure of AI involvement can reduce patient trust (dropping from 0.50 to 0.30–0.34 in experimental settings). A "paradox of knowledge" was identified, where higher patient literacy regarding AI correlates with increased skepticism. Regarding clinical autonomy, a dichotomy exists: junior clinicians are prone to automation bias, while experts face the risk of "deskilling." The review also discusses the "Algorithmic Consultant" role and the necessity of "Triadic Decision-Making," where AI serves as a transparent partner rather than a black-box authority. Conclusions: The integration of AI requires a reconfiguration of medical practice from a technology-first approach to a human-centered design. Preserving clinical autonomy depends on adopting a "trust but verify" model and implementing XAI strategies to mitigate transparency barriers. The success of algorithmic medicine relies on maintaining the physician's judgment as the cornerstone of care, ensuring that AI functions as a supportive co-pilot.
- 25 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
Open AccessALGORITHMIC AUTHORITY VS. HUMAN TOUCH: A NARRATIVE REVIEW OF PATIENT TRUST AND CLINICAL AUTONOMY IN AI-ASSISTED DIAGNOSTICS
Introduction: Contemporary medicine is undergoing an unprecedented transformation driven by the integration of advanced artificial intelligence (AI) and large language models (LLMs) into clinical workflows. While these technologies objectively enhance diagnostic precision, their implementation creates a fundamental paradox: the increase in technological efficacy often correlates with a decline in patient trust, known as the "AI trust gap." This review examines the tension between algorithmic authority and the necessity of the "human touch," analyzing the impact of digital innovations on clinical autonomy and the patient-physician-AI triad. Materials and Methods: This study presents a detailed analysis of 44 peer-reviewed scientific articles published between 2022 and 2026. The review focuses on Clinical Decision Support Systems (CDSS) across key diagnostic areas, including radiology and pathology. The analysis encompasses the psychological mechanisms of AI acceptance, the risks of automation bias, and the potential of Explainable AI (XAI) to restore clinical transparency. Key Findings: Research reveals that the mere disclosure of AI involvement can reduce patient trust (dropping from 0.50 to 0.30–0.34 in experimental settings). A "paradox of knowledge" was identified, where higher patient literacy regarding AI correlates with increased skepticism. Regarding clinical autonomy, a dichotomy exists: junior clinicians are prone to automation bias, while experts face the risk of "deskilling." The review also discusses the "Algorithmic Consultant" role and the necessity of "Triadic Decision-Making," where AI serves as a transparent partner rather than a black-box authority. Conclusions: The integration of AI requires a reconfiguration of medical practice from a technology-first approach to a human-centered design. Preserving clinical autonomy depends on adopting a "trust but verify" model and implementing XAI strategies to mitigate transparency barriers. The success of algorithmic medicine relies on maintaining the physician's judgment as the cornerstone of care, ensuring that AI functions as a supportive co-pilot.
- Open Access
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
EMERGING DIGITAL TECHNOLOGIES IN MONITORING ENDOCRINE DISORDERS: CONTINUOUS GLUCOSE MONITORING SYSTEMS AND ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
Introduction and objective: Endocrine disorders affect the regulation of metabolic processes and are often associated with disturbances in glucose and hormonal homeostasis. In recent years, digital tools have increasingly contributed to the diagnosis and monitoring of metabolic diseases. Technological advancements have introduced continuous glucose monitoring (CGM) for patients with diabetes, as well as artificial intelligence (AI) algorithms to support the assessment of hormonal and imaging parameters in the diagnosis of PCOS. Despite these advances, studies on patients with diabetes using CGM who are simultaneously diagnosed with PCOS remain limited. AI-based diagnostic tools show promising accuracy in detecting PCOS characteristics through hormonal profiles and ultrasound imaging. The aim of this review is to summarize current evidence on CGM systems and AI in the evaluation and diagnosis of endocrine disorders, focusing on diabetes and PCOS. Methods: This narrative review analyzed literature from 2019–2025 and one earlier publication using PubMed and Google Scholar, focusing on CGM, AI, and diagnostic approaches in endocrine disorders. Results: CGM provides valuable insight into glucose variability and metabolic patterns in diabetes, but evidence for its use in patients with concurrent PCOS is limited. AI-based tools demonstrate high accuracy in identifying PCOS features, especially through hormonal profiling and ultrasound analysis. Conclusion: Digital technologies such as CGM and AI offer promising opportunities to improve the evaluation and management of endocrine disorders, particularly in women with PCOS. Larger, standardized studies are needed to validate clinical utility and support integration into routine care.
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Open AccessEMERGING DIGITAL TECHNOLOGIES IN MONITORING ENDOCRINE DISORDERS: CONTINUOUS GLUCOSE MONITORING SYSTEMS AND ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
Introduction and objective: Endocrine disorders affect the regulation of metabolic processes and are often associated with disturbances in glucose and hormonal homeostasis. In recent years, digital tools have increasingly contributed to the diagnosis and monitoring of metabolic diseases. Technological advancements have introduced continuous glucose monitoring (CGM) for patients with diabetes, as well as artificial intelligence (AI) algorithms to support the assessment of hormonal and imaging parameters in the diagnosis of PCOS. Despite these advances, studies on patients with diabetes using CGM who are simultaneously diagnosed with PCOS remain limited. AI-based diagnostic tools show promising accuracy in detecting PCOS characteristics through hormonal profiles and ultrasound imaging. The aim of this review is to summarize current evidence on CGM systems and AI in the evaluation and diagnosis of endocrine disorders, focusing on diabetes and PCOS. Methods: This narrative review analyzed literature from 2019–2025 and one earlier publication using PubMed and Google Scholar, focusing on CGM, AI, and diagnostic approaches in endocrine disorders. Results: CGM provides valuable insight into glucose variability and metabolic patterns in diabetes, but evidence for its use in patients with concurrent PCOS is limited. AI-based tools demonstrate high accuracy in identifying PCOS features, especially through hormonal profiling and ultrasound analysis. Conclusion: Digital technologies such as CGM and AI offer promising opportunities to improve the evaluation and management of endocrine disorders, particularly in women with PCOS. Larger, standardized studies are needed to validate clinical utility and support integration into routine care.
- Open Access
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
ORAL MUCOSAL CHANGES IN COELIAC DISEASE, DIABETES MELLITUS, AND INFLAMMATORY BOWEL DISEASES – A SYSTEMATIC REVIEW
Background: The oral cavity is sometimes referred to as a “diagnostic window” of systemic health, as even subtle systemic disturbances can manifest as changes in the oral mucosa. Coeliac disease, diabetes mellitus, and inflammatory bowel diseases (IBD) are chronic conditions that frequently present with oral mucosal lesions, which may precede or accompany the classical symptoms of these diseases. Aim: To systematically review and compare the oral mucosal changes reported in coeliac disease, diabetes mellitus, and IBD. The most common clinical manifestations are characterized, potential pathophysiological mechanisms are discussed, and the relevance of oral findings for early recognition and monitoring of these systemic diseases is evaluated. Materials and Methods: A systematic literature search was conducted in PubMed and Google Scholar using combinations of English keywords (including “oral mucosa,” “oral manifestations,” “coeliac disease,” “diabetes mellitus,” “inflammatory bowel disease,” “Crohn’s disease,” “ulcerative colitis,” “aphthous ulcers,” “xerostomia,” “oral microbiome,” and “oral–gut axis”). A total of 37 relevant peer-reviewed articles (clinical studies and reviews) were identified and analyzed. Results: The most frequently described oral manifestations in these conditions include recurrent aphthous stomatitis, inflammatory and atrophic changes of the tongue (such as geographic tongue and atrophic glossitis), angular cheilitis, xerostomia, and recurrent opportunistic infections (especially oral candidosis). In coeliac disease, oral lesions (aphthae, glossitis, cheilitis) and dental enamel defects often occur, sometimes even years before diagnosis, and tend to improve after the introduction of a strict gluten-free diet. Diabetes is associated with salivary gland dysfunction leading to dry mouth, elevated salivary glucose, and immune dysfunction – factors that contribute to candidosis, poor wound healing, burning mouth sensations, and an increased incidence of oral ulcers. IBD (Crohn’s disease and ulcerative colitis) can produce a broad spectrum of oral changes: Crohn’s disease in particular is characterized by specific granulomatous lesions (such as persistent lip swelling, mucosal “cobblestoning,” and deep linear ulcers) as well as nonspecific lesions (recurrent aphthae, pyostomatitis vegetans, glossitis, cheilitis). Oral manifestations of IBD are more common in Crohn’s disease and in pediatric patients and can precede intestinal symptoms or correlate with intestinal disease activity. Conclusions: Oral mucosal changes represent an important extraintestinal component of coeliac disease, diabetes, and IBD. They can serve as early warning signs of these disorders or indicators of disease activity and control. Recognition of characteristic oral lesions by dentists and physicians is crucial, as it can expedite diagnosis and prompt timely management (e.g. initiation of a gluten-free diet in coeliac disease or improved glycemic control in diabetes). Regular oral examinations should be an integral part of the care of patients with these conditions. Interdisciplinary collaboration – especially between dentists, gastroenterologists, and diabetologists – is essential for early detection, comprehensive monitoring, and improved patient outcomes.
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Open AccessORAL MUCOSAL CHANGES IN COELIAC DISEASE, DIABETES MELLITUS, AND INFLAMMATORY BOWEL DISEASES – A SYSTEMATIC REVIEW
Background: The oral cavity is sometimes referred to as a “diagnostic window” of systemic health, as even subtle systemic disturbances can manifest as changes in the oral mucosa. Coeliac disease, diabetes mellitus, and inflammatory bowel diseases (IBD) are chronic conditions that frequently present with oral mucosal lesions, which may precede or accompany the classical symptoms of these diseases. Aim: To systematically review and compare the oral mucosal changes reported in coeliac disease, diabetes mellitus, and IBD. The most common clinical manifestations are characterized, potential pathophysiological mechanisms are discussed, and the relevance of oral findings for early recognition and monitoring of these systemic diseases is evaluated. Materials and Methods: A systematic literature search was conducted in PubMed and Google Scholar using combinations of English keywords (including “oral mucosa,” “oral manifestations,” “coeliac disease,” “diabetes mellitus,” “inflammatory bowel disease,” “Crohn’s disease,” “ulcerative colitis,” “aphthous ulcers,” “xerostomia,” “oral microbiome,” and “oral–gut axis”). A total of 37 relevant peer-reviewed articles (clinical studies and reviews) were identified and analyzed. Results: The most frequently described oral manifestations in these conditions include recurrent aphthous stomatitis, inflammatory and atrophic changes of the tongue (such as geographic tongue and atrophic glossitis), angular cheilitis, xerostomia, and recurrent opportunistic infections (especially oral candidosis). In coeliac disease, oral lesions (aphthae, glossitis, cheilitis) and dental enamel defects often occur, sometimes even years before diagnosis, and tend to improve after the introduction of a strict gluten-free diet. Diabetes is associated with salivary gland dysfunction leading to dry mouth, elevated salivary glucose, and immune dysfunction – factors that contribute to candidosis, poor wound healing, burning mouth sensations, and an increased incidence of oral ulcers. IBD (Crohn’s disease and ulcerative colitis) can produce a broad spectrum of oral changes: Crohn’s disease in particular is characterized by specific granulomatous lesions (such as persistent lip swelling, mucosal “cobblestoning,” and deep linear ulcers) as well as nonspecific lesions (recurrent aphthae, pyostomatitis vegetans, glossitis, cheilitis). Oral manifestations of IBD are more common in Crohn’s disease and in pediatric patients and can precede intestinal symptoms or correlate with intestinal disease activity. Conclusions: Oral mucosal changes represent an important extraintestinal component of coeliac disease, diabetes, and IBD. They can serve as early warning signs of these disorders or indicators of disease activity and control. Recognition of characteristic oral lesions by dentists and physicians is crucial, as it can expedite diagnosis and prompt timely management (e.g. initiation of a gluten-free diet in coeliac disease or improved glycemic control in diabetes). Regular oral examinations should be an integral part of the care of patients with these conditions. Interdisciplinary collaboration – especially between dentists, gastroenterologists, and diabetologists – is essential for early detection, comprehensive monitoring, and improved patient outcomes.
- Open Access
- 29 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
LIFESTYLE AND AUTOIMMUNITY: HOW MODERN HABITS SHAPE IMMUNE DYSREGULATION
According to current estimates, between 80 and 150 autoimmune diseases have been identified. In the United States alone, over 50 million individuals live with an autoimmune condition. These disorders substantially impact healthcare expenditures and, most importantly, the quality of life, mental health, and physical functioning of affected patients. Epidemiological data indicate a steady increase in both the incidence and recognition of autoimmune diseases. Modern lifestyle factors exert a profound influence on immune system function and may contribute to their development. This review discusses key everyday habits—such as stress, physical activity, the use of substances (alcohol consumption, smoking), contemporary dietary patterns, the growing epidemic of obesity, sleep, as well as infections with pathogens such as SARS-CoV-2—that modulate immune responses and promote their dysregulation. This article is a comprehensive review based on studies retrieved from scientific databases such as PubMed and Google Scholar, with sources selected for their relevance and significance to the topic. The analysis indicates that chronic stress, sleep deprivation, substance use, and highly processed diets exacerbate inflammatory processes, immunosenescence, and inflammaging, thereby increasing susceptibility to autoimmunity. Conversely, health-promoting non-pharmacological interventions—including lifestyle modification, stress-regulation techniques, and regular physical activity—may alleviate immunological disturbances and improve patients’ functioning and quality of life. In light of current evidence, an integrated approach that combines medical treatment with lifestyle interventions represents a key component of both the prevention and management of autoimmune disorders.
- 29 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessLIFESTYLE AND AUTOIMMUNITY: HOW MODERN HABITS SHAPE IMMUNE DYSREGULATION
According to current estimates, between 80 and 150 autoimmune diseases have been identified. In the United States alone, over 50 million individuals live with an autoimmune condition. These disorders substantially impact healthcare expenditures and, most importantly, the quality of life, mental health, and physical functioning of affected patients. Epidemiological data indicate a steady increase in both the incidence and recognition of autoimmune diseases. Modern lifestyle factors exert a profound influence on immune system function and may contribute to their development. This review discusses key everyday habits—such as stress, physical activity, the use of substances (alcohol consumption, smoking), contemporary dietary patterns, the growing epidemic of obesity, sleep, as well as infections with pathogens such as SARS-CoV-2—that modulate immune responses and promote their dysregulation. This article is a comprehensive review based on studies retrieved from scientific databases such as PubMed and Google Scholar, with sources selected for their relevance and significance to the topic. The analysis indicates that chronic stress, sleep deprivation, substance use, and highly processed diets exacerbate inflammatory processes, immunosenescence, and inflammaging, thereby increasing susceptibility to autoimmunity. Conversely, health-promoting non-pharmacological interventions—including lifestyle modification, stress-regulation techniques, and regular physical activity—may alleviate immunological disturbances and improve patients’ functioning and quality of life. In light of current evidence, an integrated approach that combines medical treatment with lifestyle interventions represents a key component of both the prevention and management of autoimmune disorders.
- Open Access
- 23 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
PRECISION MEDICINE IN BREAST RECONSTRUCTION: CLINICAL ADVANCES, REHABILITATION AND PATIENT EDUCATION PERSPECTIVES
Introduction: Breast cancer represents the most frequently diagnosed malignancy among women globally, affecting approximately 2.12 million new cases annually according to the Global Burden of Disease 2021 analysis. While radical mastectomy remains the primary surgical treatment, it often results in significant chest wall defects and axillary distortion with profound negative impacts on body image, psychological well-being, and overall quality of life (QoL). Breast reconstruction has evolved into an integral component of modern oncological treatment, extending beyond aesthetic considerations to encompass comprehensive patient-reported outcomes and functional recovery. Contemporary healthcare increasingly embraces precision medicine principles, wherein breast reconstruction serves as a paradigmatic field requiring personalized treatment algorithms that balance oncological safety, aesthetic outcomes, and patient-specific variables. This comprehensive review synthesizes current evidence on precision medicine approaches in breast reconstruction, examining surgical innovations, postoperative rehabilitation strategies, and patient-centered outcome assessment. Materials and Methods: This review constitutes a thorough analysis of peer-reviewed literature obtained from the PubMed scientific database, synthesizing materials spanning from the Introduction through References of the manuscript. The analysis encompasses recent advances in surgical techniques, rehabilitation protocols, bioengineered technologies, and patient-reported outcome measures employed in breast reconstruction following mastectomy. Key Findings: Contemporary breast reconstruction integrates three interdependent pillars: advanced surgical techniques, targeted postoperative rehabilitation, and precise patient-centered outcome assessment via validated tools such as BREAST-Q. Modern surgical strategies include nipple-sparing mastectomy (NSM) with immediate reconstruction, prepectoral breast reconstruction utilizing acellular dermal matrices (ADM), and autologous free flap techniques (particularly DIEP flaps). Enhanced Recovery After Surgery (ERAS) protocols significantly reduce hospitalization duration to post-operative day 3 with equivalent complication rates compared to traditional protocols. Early mobilization and structured physical therapy demonstrably improve shoulder range of motion and functional outcomes. Patient-reported outcomes consistently demonstrate that autologous reconstruction produces superior satisfaction and health-related quality of life compared to implant-based approaches. Emerging tissue engineering technologies, including three-dimensional bioprinting, adipose-derived stem cells, and bioengineered scaffolds, represent promising future directions for functional breast reconstruction with reduced morbidity. Conclusions: Precision medicine in breast reconstruction requires integrated decision-making incorporating molecular data, clinical variables, and subjective patient experiences throughout all treatment phases. Optimal outcomes depend upon personalized surgical strategy selection, early and targeted rehabilitation, and standardized measurement of patient-reported outcomes. This multifaceted, precision-based approach ensures maximal functional and psychological benefits while minimizing procedural morbidity, ultimately delivering comprehensive quality of life improvements for breast cancer survivors.
- 23 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessPRECISION MEDICINE IN BREAST RECONSTRUCTION: CLINICAL ADVANCES, REHABILITATION AND PATIENT EDUCATION PERSPECTIVES
Introduction: Breast cancer represents the most frequently diagnosed malignancy among women globally, affecting approximately 2.12 million new cases annually according to the Global Burden of Disease 2021 analysis. While radical mastectomy remains the primary surgical treatment, it often results in significant chest wall defects and axillary distortion with profound negative impacts on body image, psychological well-being, and overall quality of life (QoL). Breast reconstruction has evolved into an integral component of modern oncological treatment, extending beyond aesthetic considerations to encompass comprehensive patient-reported outcomes and functional recovery. Contemporary healthcare increasingly embraces precision medicine principles, wherein breast reconstruction serves as a paradigmatic field requiring personalized treatment algorithms that balance oncological safety, aesthetic outcomes, and patient-specific variables. This comprehensive review synthesizes current evidence on precision medicine approaches in breast reconstruction, examining surgical innovations, postoperative rehabilitation strategies, and patient-centered outcome assessment. Materials and Methods: This review constitutes a thorough analysis of peer-reviewed literature obtained from the PubMed scientific database, synthesizing materials spanning from the Introduction through References of the manuscript. The analysis encompasses recent advances in surgical techniques, rehabilitation protocols, bioengineered technologies, and patient-reported outcome measures employed in breast reconstruction following mastectomy. Key Findings: Contemporary breast reconstruction integrates three interdependent pillars: advanced surgical techniques, targeted postoperative rehabilitation, and precise patient-centered outcome assessment via validated tools such as BREAST-Q. Modern surgical strategies include nipple-sparing mastectomy (NSM) with immediate reconstruction, prepectoral breast reconstruction utilizing acellular dermal matrices (ADM), and autologous free flap techniques (particularly DIEP flaps). Enhanced Recovery After Surgery (ERAS) protocols significantly reduce hospitalization duration to post-operative day 3 with equivalent complication rates compared to traditional protocols. Early mobilization and structured physical therapy demonstrably improve shoulder range of motion and functional outcomes. Patient-reported outcomes consistently demonstrate that autologous reconstruction produces superior satisfaction and health-related quality of life compared to implant-based approaches. Emerging tissue engineering technologies, including three-dimensional bioprinting, adipose-derived stem cells, and bioengineered scaffolds, represent promising future directions for functional breast reconstruction with reduced morbidity. Conclusions: Precision medicine in breast reconstruction requires integrated decision-making incorporating molecular data, clinical variables, and subjective patient experiences throughout all treatment phases. Optimal outcomes depend upon personalized surgical strategy selection, early and targeted rehabilitation, and standardized measurement of patient-reported outcomes. This multifaceted, precision-based approach ensures maximal functional and psychological benefits while minimizing procedural morbidity, ultimately delivering comprehensive quality of life improvements for breast cancer survivors.
- Open Access
- 22 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 86, 66950
Melatonin deficiency and sleep fragmentation in frequent travelers: A modern circadian health crisis
Background: Frequent travel disrupts the circadian rhythm, often leading to disturbed melatonin production. This disruption contributes to sleep fragmentation, reduces sleep quality, and cumulative fatigue that many travelers experience as more than just temporary jet lag. Despite the growing spread of global travel, the long-term consequences of melatonin deficiency and chronic circadian misalignment remain underrecognized and insufficiently addressed. Aim: To review the available literature on how frequent travel leads to melatonin deficiency and sleep fragmentation and to highlight the need for better strategies to address this growing circadian health issue. Methods: A narrative review was conducted using 35 peer-reviewed articles identified through PubMed, Scopus, and Google Scholar. The studies were organized into six thematic categories: biological mechanisms of melatonin production, circadian rhythm disturbances and frequent long-distance travel (jet lag), sleep fragmentation – mechanisms and consequences, correlation between melatonin deficiency and sleep fragmentation, long-term health issues and current intervention strategies. Results: Melatonin deficiency and sleep fragmentation in frequent travelers, by disrupting the central circadian rhythm, are associated with a number of serious long-term health consequences, such as neurodegeneration and cognitive impairment, metabolic disorders and cardiovascular diseases, diabetes, obesity, mental health issues and increased risk of cancer. Further research is needed to develop better strategies for managing circadian rhythm disruption and reducing its long-term effects. Conclusions: The circadian rhythm dysfunction is closely connected to many future health problems. Addressing this growing issue requires greater awareness and more effective, evidence-based strategies to support circadian stability in those who travel regularly.
- 22 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 86, 66950
Open AccessMelatonin deficiency and sleep fragmentation in frequent travelers: A modern circadian health crisis
Background: Frequent travel disrupts the circadian rhythm, often leading to disturbed melatonin production. This disruption contributes to sleep fragmentation, reduces sleep quality, and cumulative fatigue that many travelers experience as more than just temporary jet lag. Despite the growing spread of global travel, the long-term consequences of melatonin deficiency and chronic circadian misalignment remain underrecognized and insufficiently addressed. Aim: To review the available literature on how frequent travel leads to melatonin deficiency and sleep fragmentation and to highlight the need for better strategies to address this growing circadian health issue. Methods: A narrative review was conducted using 35 peer-reviewed articles identified through PubMed, Scopus, and Google Scholar. The studies were organized into six thematic categories: biological mechanisms of melatonin production, circadian rhythm disturbances and frequent long-distance travel (jet lag), sleep fragmentation – mechanisms and consequences, correlation between melatonin deficiency and sleep fragmentation, long-term health issues and current intervention strategies. Results: Melatonin deficiency and sleep fragmentation in frequent travelers, by disrupting the central circadian rhythm, are associated with a number of serious long-term health consequences, such as neurodegeneration and cognitive impairment, metabolic disorders and cardiovascular diseases, diabetes, obesity, mental health issues and increased risk of cancer. Further research is needed to develop better strategies for managing circadian rhythm disruption and reducing its long-term effects. Conclusions: The circadian rhythm dysfunction is closely connected to many future health problems. Addressing this growing issue requires greater awareness and more effective, evidence-based strategies to support circadian stability in those who travel regularly.
- Open Access
- 29 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
SPICES AS ERGOGENIC AIDS: IMPACT ON EXERCISE PERFORMANCE, MUSCLE RECOVERY, AND INFLAMMATION IN ATHLETES – A SYSTEMATIC REVIEW
Background: Spices like capsaicin, turmeric, ginger, piperine, garlic, and cinnamon have been used in cooking and folk medicine for centuries. Modern research shows their ergogenic, anti-inflammatory, and antioxidant properties, aiding athletic performance, muscle recovery, and overall health. Aim: This review analyzes effects of these spices on physically active individuals (mechanisms, benefits, limitations). Materials and methods: Studies from PubMed, MDPI, Quality in Sport, and Journal of Pharmaceutical Research International on ergogenic, anti-inflammatory, and antioxidant effects of capsaicin, turmeric, ginger, piperine, garlic, and cinnamon in physically active people. Results: Capsaicin shows thermogenic effects and supports fat metabolism, boosting exercise performance, but GI effects need study. Turmeric, via curcumin, offers anti-inflammatory and antioxidant benefits, reducing muscle damage and speeding recovery despite low bioavailability. Ginger modulates cellular metabolism to aid muscle recovery and ease post-exercise pain. Piperine enhances nutrient bioavailability, improves muscle strength, and optimizes energy metabolism with low-risk toxicity. Garlic reduces oxidative stress and inflammation, strengthens immunity, and relieves muscle fatigue. Cinnamon provides hypoglycemic and antioxidant properties, improving glucose/lipid metabolism and cardiovascular health in athletes. Conclusions: These spices show promise as phytonutrients in sports medicine. Their anti-inflammatory, antioxidant, and metabolic effects enhance performance and recovery by increasing muscle strength, reducing DOMS, shortening recovery, and lowering inflammation. Synergies like piperine-curcumin amplify efficacy. Challenges like poor bioavailability (e.g., curcumin) and inconsistent evidence require rigorous studies for optimal dosages, formulations, and protocols.
- 29 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
Open AccessSPICES AS ERGOGENIC AIDS: IMPACT ON EXERCISE PERFORMANCE, MUSCLE RECOVERY, AND INFLAMMATION IN ATHLETES – A SYSTEMATIC REVIEW
Background: Spices like capsaicin, turmeric, ginger, piperine, garlic, and cinnamon have been used in cooking and folk medicine for centuries. Modern research shows their ergogenic, anti-inflammatory, and antioxidant properties, aiding athletic performance, muscle recovery, and overall health. Aim: This review analyzes effects of these spices on physically active individuals (mechanisms, benefits, limitations). Materials and methods: Studies from PubMed, MDPI, Quality in Sport, and Journal of Pharmaceutical Research International on ergogenic, anti-inflammatory, and antioxidant effects of capsaicin, turmeric, ginger, piperine, garlic, and cinnamon in physically active people. Results: Capsaicin shows thermogenic effects and supports fat metabolism, boosting exercise performance, but GI effects need study. Turmeric, via curcumin, offers anti-inflammatory and antioxidant benefits, reducing muscle damage and speeding recovery despite low bioavailability. Ginger modulates cellular metabolism to aid muscle recovery and ease post-exercise pain. Piperine enhances nutrient bioavailability, improves muscle strength, and optimizes energy metabolism with low-risk toxicity. Garlic reduces oxidative stress and inflammation, strengthens immunity, and relieves muscle fatigue. Cinnamon provides hypoglycemic and antioxidant properties, improving glucose/lipid metabolism and cardiovascular health in athletes. Conclusions: These spices show promise as phytonutrients in sports medicine. Their anti-inflammatory, antioxidant, and metabolic effects enhance performance and recovery by increasing muscle strength, reducing DOMS, shortening recovery, and lowering inflammation. Synergies like piperine-curcumin amplify efficacy. Challenges like poor bioavailability (e.g., curcumin) and inconsistent evidence require rigorous studies for optimal dosages, formulations, and protocols.